DNA vaccine targeting Trp2/Gp100 tumor antigen (Wistar Institute)

N/A

Report date: 2025/12/18 17:46:30

Base Information

Drug NameDNA vaccine targeting Trp2/Gp100 tumor antigen (Wistar Institute)
Drug Alias Nameantitumor vaccine (Wistar Institute of Anatomy & Biology)DLnano-vaccines (Wistar Institute)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMelanomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Wistar Institute Of Anatomy And Biology
China Registration ClassN/A

Develop Information

Active CompaniesThe Wistar Institute Of Anatomy And Biology
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A